S&P 500
(-0.13%) 5 462.02 points
Dow Jones
(-0.36%) 38 970 points
Nasdaq
(0.27%) 17 765 points
Oil
(0.35%) $81.11
Gas
(-3.48%) $2.66
Gold
(-0.95%) $2 308.60
Silver
(-0.39%) $28.76
Platinum
(1.53%) $1 001.50
USD/EUR
(0.28%) $0.936
USD/NOK
(0.86%) $10.69
USD/GBP
(0.38%) $0.791
USD/RUB
(-0.27%) $87.25

リアルタイムの更新: RayzeBio, Inc. Common [RYZB]

取引所: NASDAQ セクター: Healthcare 産業: Biotechnology
最終更新日時24 2月 2024 @ 06:00

0.02% $ 62.49

Live Chart Being Loaded With Signals

Commentary (24 2月 2024 @ 06:00):

RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company’s lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs)...

Stats
本日の出来高 282 719
平均出来高 745 490
時価総額 3.75B
EPS $-1.180 ( Q3 | 2023-09-30 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -57.86
(Sector) 42.63
(Industry) 24.32
ATR14 $0.455 (0.73%)
AADI -1.18%
ABCL 1.98%
ABCM 0.04%
ABEO -3.55%
ABIO -0.28%
ABOS -2.33%
ABSI 0.51%
ABUS -3.11%
ABVX -2.56%
ACAD -1.60%
ACER -17.95%
ACET -4.01%
ACGN 1.29%
ACHL -4.15%
ACHV -0.11%
ACIU -0.87%
ACLX -0.70%
ACRV -3.12%
ACST -1.30%
ACXP 0.36%
ADAG 1.82%
ADAP -2.10%
ADGI 0.87%
ADIL 0.88%
ADMA -2.59%
ADPT 0.44%
ADTX -4.86%
ADVM -2.60%
ADXN -1.60%
AEON -1.10%
AEZS -3.51%
AFMD -2.96%
AGEN -0.54%
AGIO -1.30%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -5.42%
AKRO -3.40%
AKTX 3.23%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -3.67%
ALGS -3.70%
ALKS -0.25%
ALLK -8.94%
ALLO -5.63%
ALLR -0.87%
ALNA 3.16%
ALNY 0.33%
ALPN 0.02%
ALPX 0.00%
ALRN -1.67%
ALT -9.50%
ALVR -2.65%
ALXN 0.00%
ALXO -10.65%
ALZN -2.05%
AMRN 1.61%
AMTI -3.13%
ANAB -0.04%
ANEB -4.55%
ANGN 0.00%
ANIX -1.40%
ANL -3.22%
ANNX -2.18%
ANPC -3.15%
APGE -1.04%
APGN 8.48%
APGNW 30.65%
APLM 0.61%
APLS -0.53%
APLT -4.17%
APM -1.47%
APOP 0.38%
APRE 2.29%
APTO 3.38%
APTX 3.17%
APVO 0.95%
ARAV -13.39%
ARCT -4.68%
ARDS -14.23%
ARDX -1.41%
ARGX -1.16%
ARNA 0.00%
ARPO -0.90%
ARQT -1.09%
ARTL -3.62%
ARTLW 0.00%
ARVN 3.27%
ARWR -3.16%
ASLN -1.83%
ASMB -0.65%
ASND -2.58%
ATAI -1.11%
ATHA 5.71%
ATHE 1.12%
ATHX -33.50%
ATNF -0.98%
ATOS 5.34%
ATRA 0.00%
ATXI 0.00%
ATXS -0.72%
AUPH -1.35%
AURA 0.37%
AUTL -1.15%
AVBP -7.15%
AVEO 0.00%
AVIR -0.58%
AVRO -1.41%
AVTE -4.83%
AVTX -1.25%
AVXL -2.47%
AXLA 0.00%
AXSM -2.00%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 1.11%
BCAB 2.62%
BCDA -1.55%
BCDAW -41.77%
BCEL 0.00%
BCLI 7.86%
BCRX -0.58%
BCTX 4.03%
BCTXW -16.28%
BCYC 0.20%
BDRX -2.33%
BDTX -1.07%
BEAM -1.11%
BFRA -2.91%
BGNE -2.97%
BIOR -3.79%
BIVI -0.38%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.02%
BLTE -0.62%
BLU 0.03%
BLUE -1.56%
BMEA -7.18%
BMRN -0.46%
BNOX -2.51%
BNTC -2.11%
BNTX -1.20%
BOLD -8.58%
BOLT -0.05%
BPMC -0.80%
BPTH 0.48%
BPTS -13.47%
BRNS -1.31%
BRTX -0.94%
BTAI 9.77%
BTTX 1.35%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 5.08%
CABA -0.90%
CADL -0.33%
CALA 0.00%
CALC -1.57%
CALT -0.67%
CAPR -3.02%
CARA 5.34%
CARM 2.60%
CASI -3.72%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -5.61%
CCCC -2.76%
CCXI 0.00%
CDAK 0.00%
CDIO -5.63%
CDIOW 24.00%
CDMO -1.69%
CDMOP 0.04%
CDT -0.81%
CDTTW -39.60%
CDTX -1.05%
CDXC -1.02%
CDXS 4.84%
CELC -3.21%
CELU -3.33%
CELUW 11.80%
CERC -1.68%
CERE -0.43%
CERO -5.39%
CEROW 0.60%
CFRX -27.95%
CGEM -3.66%
CGEN -3.31%
CGON -0.67%
CGTX -1.14%
CHMA -6.00%
CHRS -0.63%
CINC 0.00%
CING 2.39%
CINGW 34.95%
CKPT -2.63%
CLBS -16.75%
CLDX -3.36%
CLGN 0.14%
CLLS -4.04%
CLNN 2.39%
CLNNW 0.00%
CLRB 5.56%
CLSD -2.00%
CLSN -0.68%
CLVS 0.00%
CMMB 0.97%
CMND 4.84%
CMPI 0.00%
CMPX -3.77%
CMRA 0.00%
CMRAW 33.33%
CMRX -1.63%
CNCE 0.00%
CNSP -38.52%
CNST 0.00%
CNTA -0.45%
CNTB -1.50%
CNTX -5.02%
COCP -2.78%
COEPW 32.45%
COGT -2.88%
CORT 1.55%
COYA 1.79%
CPRX -0.79%
CRBP -2.68%
CRBU -4.71%
CRDF -2.22%
CRGX -0.47%
CRIS -0.38%
CRNX -4.58%
CRSP -0.50%
CRTX 2.63%
CRVO -4.75%
CRVS 1.12%
CSBR -1.59%
CTCX -11.35%
CTIC 0.06%
CTMX -1.65%
CTNM 0.00%
CTXR 2.97%
CUE 6.25%
CVAC -1.27%
CVKD 0.15%
CWBR 2.80%
CYAD -12.96%
CYCC 10.06%
CYCCP 5.49%
CYCN 2.61%
CYT -2.27%
CYTK -2.14%
CYTO -2.73%
DARE 3.31%
DAWN -1.76%
DBTX -0.81%
DBVT 0.91%
DFFN 10.28%
DICE 0.06%
DMAC 19.36%
DNLI -1.65%
DNTH -6.17%
DOMH -1.58%
DRMA -2.15%
DRMAW -1.25%
DRNA 0.00%
DRTS 4.63%
DRTSW 0.00%
DRUG -7.39%
DSGN -0.34%
DTIL 0.89%
DYAI 6.45%
EARS -1.77%
EDIT -3.02%
EDSA -1.00%
EFTR 7.10%
EFTRW -74.07%
EIGR -9.21%
ELAB -2.01%
ELDN 6.72%
ELEV -4.56%
ELOX 7.69%
ELTX -0.88%
ELVN -4.94%
ELYM -3.91%
ENGN -0.33%
ENGNW 0.12%
ENLV 2.54%
ENOB 1.79%
ENSC 5.75%
ENTA -1.47%
ENTO -3.85%
ENTX -1.10%
ENVB 1.42%
EPIX -0.72%
EPRX -2.97%
EPZM 0.00%
EQ 0.44%
EQRX -2.09%
EQRXW 0.00%
ERAS -0.24%
ERNA -0.96%
ERYP 1.30%
ESLA 4.30%
ESLAW 87.05%
ETNB -1.91%
ETON 0.46%
ETTX 0.00%
EVAX -2.67%
EVGN 3.26%
EVLO 0.00%
EWTX -0.29%
EXAI 0.00%
EXEL -0.49%
EYEG -0.69%
EYEN 4.52%
EYPT -0.44%
FATE -6.99%
FBIO 0.59%
FBIOP 0.32%
FBLG -7.98%
FBRX -6.12%
FDMT -5.14%
FENC -1.29%
FGEN -4.70%
FHTX 1.72%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.38%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -1.20%
FULC -4.01%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.50%
GANX -2.31%
GBIO -2.83%
GBT 0.01%
GDTC 0.50%
GERN -4.19%
GHRS -2.59%
GLMD 0.50%
GLPG -2.34%
GLSI 1.43%
GLTO -0.18%
GLUE -3.43%
GLYC -13.20%
GMAB -0.16%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -0.52%
GNLX 1.33%
GNPX 0.93%
GNTA 3.94%
GOSS -4.29%
GOVX -9.55%
GOVXW -49.04%
GPCR -5.22%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 2.71%
GRTX 2.12%
GTHX 0.23%
GUTS -4.39%
GXGXW 41.67%
GYRE -2.32%
HALO -1.20%
HARP 0.09%
HCWB -7.81%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX 0.73%
HOOK 2.77%
HOTH -1.61%
HOWL -1.71%
HRMY -0.20%
HRTX 0.66%
HSTO 0.00%
HUMA 1.27%
HUMAW -0.01%
IBRX -4.95%
ICCC 0.22%
ICPT 0.21%
ICU 18.70%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.61%
IFRX -1.55%
IGMS -0.58%
IKNA 0.00%
IKT 1.42%
IMAB -1.74%
IMCR -3.39%
IMGN 0.02%
IMGO 0.00%
IMMP 4.17%
IMMX -3.53%
IMNM -3.21%
IMNN 2.34%
IMPL -27.27%
IMRA 15.96%
IMRN 0.00%
IMRX -1.05%
IMTX -1.71%
IMTXW 6.00%
IMUX 0.93%
IMV 0.00%
IMVT -2.69%
INAB -0.45%
INBX -1.19%
INCY -1.20%
INDP 10.20%
INFI -52.38%
INKT 0.01%
INM -5.90%
INMB 0.77%
INO -3.64%
INSM -0.56%
INTS -1.47%
INVA 0.14%
INZY 0.69%
IOBT -9.45%
IONS -0.72%
IOVA -2.25%
IPA 3.00%
IPHA 5.58%
IPSC -0.88%
IRON -3.42%
ISEE 0.38%
ITOS -1.37%
ITRM 2.50%
IVA 6.96%
IVVD -0.83%
JAGX 0.40%
JANX -3.62%
JAZZ -1.32%
JNCE 0.00%
JSPR -6.50%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -8.91%
KALV -1.73%
KDNY 0.22%
KMPH -0.34%
KNSA -2.69%
KNTE -0.38%
KOD -5.14%
KPRX -0.23%
KPTI -0.46%
KRBP -10.00%
KRON 1.06%
KROS -1.42%
KRRO -3.41%
KRTX 0.03%
KRYS -1.49%
KTRA 10.60%
KTTA 8.16%
KTTAW 0.92%
KURA -1.76%
KYMR -2.66%
KYTX -4.65%
KZIA 9.01%
KZR -0.21%
LABP 0.57%
LBPH -0.69%
LBPS 0.00%
LBPSW 14.81%
LEGN 0.76%
LENZ -7.69%
LEXX -0.78%
LEXXW -14.63%
LGND -1.06%
LGNDV 0.00%
LGVN -9.04%
LIAN -8.28%
LIFE 2.70%
LIPO -11.00%
LIXT -3.77%
LIXTW 95.35%
LJPC -0.32%
LMNL 0.12%
LOGC -0.35%
LPCN -4.01%
LPTX -1.09%
LQDA -0.33%
LRMR -0.78%
LSTA -4.06%
LTRN 1.00%
LUMO -1.32%
LVTX 0.41%
LXEO -3.35%
LXRX -2.65%
LYEL -28.91%
LYRA -1.82%
MACK 0.10%
MBIO -10.90%
MBRX -0.71%
MCRB 5.85%
MDGL -3.27%
MDNA -13.16%
MDWD 0.48%
MDXG -2.50%
MEIP 0.24%
MESO -1.92%
MGNX -3.96%
MGTA -7.74%
MGTX -2.86%
MGX -2.68%
MIRM -2.07%
MIRO 0.59%
MIST 2.33%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX -1.34%
MLYS -1.60%
MNKD -0.76%
MNMD -0.50%
MNOV 1.41%
MNPR -3.72%
MOLN 0.11%
MOR 1.06%
MORF -3.49%
MREO -2.71%
MRKR 2.57%
MRNA -4.80%
MRNS -4.04%
MRSN -2.38%
MRTX -0.17%
MRUS -0.18%
MRVI -1.08%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -0.93%
MYMD 2.70%
NAMS 0.65%
NAMSW 0.43%
NAUT 1.99%
NBRV 0.71%
NBSE -1.56%
NBTX 8.20%
NCNA 1.32%
NERV -3.48%
NEXI 2.60%
NGM -1.28%
NGNE -2.02%
NKGN 4.96%
NKGNW 8.00%
NKTR -4.67%
NKTX -3.92%
NLSP -4.06%
NLSPW 26.67%
NMRA -1.14%
NMTR -42.97%
NOVN -24.84%
NRBO 12.65%
NRIX -0.38%
NRSN -6.89%
NRSNW 0.00%
NRXP -8.94%
NRXPW 14.03%
NRXS -4.23%
NTBL 5.04%
NTEC -12.45%
NTHI 0.00%
NTLA -7.08%
NTRBW -31.07%
NUVL -1.74%
NVAX -2.00%
NVCT 2.16%
NVIV -34.28%
NXTC -3.82%
NYMX -0.05%
OABI 0.53%
OABIW -10.06%
OBIO -1.46%
OBSV 0.00%
OCEA -0.70%
OCGN 3.78%
OCS -1.02%
OCUL -4.19%
OCUP 1.63%
ODT -4.27%
OKYO 1.51%
OLMA -3.97%
OMER -2.70%
OMGA 4.18%
ONCO 10.99%
ONCR -3.08%
ONCS 31.87%
ONCT -1.87%
ONCY -0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 0.77%
ORGS -0.09%
ORIC -4.15%
ORMP 14.73%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.13%
OVID -1.40%
OYST 0.00%
PALI -0.87%
PASG 1.97%
PBLA -7.50%
PBM -2.42%
PBYI 0.68%
PCSA 1.93%
PCVX -0.43%
PDSB 0.16%
PEPG 1.16%
PGEN -2.68%
PHAR 1.51%
PHAS 0.00%
PHAT -1.94%
PHIO -4.96%
PHIOW 36.47%
PHVS -5.37%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.83%
PLUR 4.35%
PMN 0.00%
PMVP 0.00%
PNT 0.16%
PPBT -1.06%
PRAX 1.47%
PRDS 0.93%
PRLD -3.43%
PROG -3.47%
PROK 0.90%
PRQR 1.19%
PRTA -3.76%
PRTC -0.08%
PRTG 1.95%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -7.93%
PSTX -1.16%
PTCT -0.50%
PTE -0.82%
PTGX -2.52%
PTIXW -49.04%
PULM 2.63%
PXMD 0.00%
PYPD 0.07%
PYXS -0.82%
QLGN -6.67%
QNCX 3.56%
QNRX 0.33%
QSI -9.80%
QSIAW -3.13%
QTTB -5.89%
QURE -1.12%
RAIN -1.63%
RANI 2.41%
RAPT -4.55%
RARE 1.39%
RCKT -6.96%
REGN -1.35%
RENB -3.42%
REPL -1.96%
RETA 0.02%
REUN -0.89%
REVB -7.03%
REVBU 3.46%
REVBW 4.38%
RGLS -3.50%
RGNX -5.19%
RIGL -1.13%
RLAY -4.73%
RLMD 0.33%
RLYB -1.01%
RNA -1.34%
RNAC -3.47%
RNAZ 1.02%
RNXT 4.79%
ROIV -1.71%
ROIVW 4.56%
RPHM 0.01%
RPRX 0.24%
RPTX -2.05%
RUBY 2.70%
RVLP -32.05%
RVMD -1.36%
RVMDW 5.10%
RVNC 0.64%
RVPH 0.25%
RVPHW 1.62%
RXDX 0.09%
RXRX -3.89%
RYTM -5.24%
RYZB 0.02%
RZLT 1.03%
SABS -1.35%
SABSW -11.81%
SAGE -0.37%
SANA -4.71%
SAVA -1.20%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 3.88%
SCPH -0.25%
SCPS 0.00%
SEEL -4.66%
SEER -0.29%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -0.92%
SGMT 1.33%
SGTX -2.56%
SIOX 22.63%
SLDB -4.57%
SLGL 2.97%
SLN -3.26%
SLNO -2.57%
SLRX 7.29%
SLS -2.14%
SMMT -0.19%
SNDX -1.02%
SNGX 0.00%
SNPX -1.69%
SONN -1.08%
SPPI -0.49%
SPRB 0.91%
SPRC -4.69%
SPRO 0.23%
SRNE -25.00%
SRPT -1.83%
SRRA 0.00%
SRRK -4.21%
SRZN -2.45%
STAB 0.00%
STOK -4.37%
STRO -5.35%
STSA 0.00%
STTK -5.77%
SURF -0.93%
SVRA -0.26%
SWTX -0.34%
SYBX 0.00%
SYRS -1.72%
TALS -0.73%
TARA -5.71%
TARS -0.64%
TBPH 0.24%
TCBP 2.66%
TCDA 0.00%
TCON -3.36%
TCRR 0.00%
TCRT 1.59%
TCRX -0.65%
TECH -0.26%
TENX -1.27%
TERN -5.10%
TFFP -3.52%
TGTX -3.08%
THRX 0.12%
TIL 0.02%
TLC 0.00%
TLSA -0.53%
TNGX -2.70%
TNXP -4.40%
TNYA -4.04%
TPST 0.97%
TRDA -2.71%
TRVI -1.53%
TRVN 4.98%
TSHA -21.50%
TSVT -3.99%
TTNP -4.07%
TVTX -1.01%
TYRA -6.12%
UBX -0.48%
UNCY -3.80%
URGN -2.91%
UTHR -0.20%
VACC 11.36%
VALN -2.50%
VAXX 168.75%
VBIV 0.76%
VBLT -8.77%
VCEL -1.49%
VCNX 9.01%
VCYT -1.19%
VERA -3.20%
VERU 1.66%
VERV -2.68%
VIGL 4.30%
VINC 1.78%
VIR -0.22%
VIRI -0.84%
VIRX 3.24%
VKTX -0.96%
VLON -13.04%
VNDA -1.71%
VOR -4.03%
VRCA -0.06%
VRDN -4.24%
VRNA -0.54%
VRPX 3.50%
VRTX 0.13%
VSTM -3.23%
VTGN -2.26%
VTVT -2.17%
VTYX -2.30%
VXRT -0.19%
VYGR -2.05%
VYNE -3.18%
VYNT 7.78%
WINT -3.24%
WVE -3.97%
XBIO 0.97%
XBIT -3.54%
XCUR 6.28%
XENE -2.59%
XERS 0.71%
XFOR 3.83%
XLO 4.43%
XLRN 0.00%
XNCR -0.36%
XOMA -1.45%
XOMAO 0.36%
XOMAP -0.82%
XRTX -7.04%
YMAB -2.21%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.24%
ZNTL -3.21%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-02-26 Viking Global Investors Lp Sell 1 743 556 Common Stock
2023-09-19 Redmile Group, Llc Buy 498 510 Common Stock
2023-09-19 Redmile Group, Llc Buy 494 687 Common Stock
2023-09-19 Redmile Group, Llc Buy 864 509 Common Stock
2023-09-19 Redmile Group, Llc Sell 498 510 Series D Preferred Stock
INSIDER POWER
-34.92
Last 21 transactions
Buy: 7 015 868 | Sell: 14 005 880

ボリューム 相関

長: 0.21 (neutral)
短: 0.00 (neutral)
Signal:(88.172) Neutral

RayzeBio, Inc. Common 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

RayzeBio, Inc. Common 相関 - 通貨/商品

The country flag -0.72
( moderate negative )
The country flag 0.34
( neutral )
The country flag 0.37
( neutral )
The country flag 0.82
( strong )
The country flag 0.69
( moderate )
The country flag 0.94
( very strong )

RayzeBio, Inc. Common 財務諸表

Annual 2022
収益: $0
総利益: $0 (0.00 %)
EPS: $-1.750
FY 2022
収益: $0
総利益: $0 (0.00 %)
EPS: $-1.750

Financial Reports:

No articles found.

RayzeBio, Inc. Common Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

RayzeBio, Inc. Common

RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company’s lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs). It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。

Total Execution Time: 2.4702560901642 seconds
Number of API calls: 3
Number of DB calls: 9